Salona Global Medical Device Corporation (TSE:EVMT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Evome Medical Technologies Inc. has enhanced its financial position by selling its non-core Simbex unit, thus reducing acquisition debt and allowing a focus on the profitable Biodex product line, including the newly launched RST and upcoming SpaceTek Knee. Their strengthened relationship with Pathward, N.A. has facilitated continued innovation and market expansion. This strategic shift is aimed at boosting operational profitability and broadening their medical technology offerings.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money